You are here: Home ยป Archives for board of directors

Bitget Acquired 1.7M Users in August, Monthly Report Highlights

VICTORIA, Seychelles, Sept. 11, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company has shared its August 2024 transparency report highlighting significant growth, adding 1.72 million users despite challenging market conditions. The cryptomarket saw sharp declines, with Bitcoin falling below $50,000, but Bitget remained resilient by integrating new features and advancing strategic initiatives.

A key highlight was the integration of Apple Pay and Google Pay, allowing users to convert fiat to crypto. This enabled Bitget’s on–ramp capabilities, making it easier for users to buy and trade cryptocurrencies globally, supporting over 140 fiat currencies and 100+ cryptocurrencies.

Bitget appointed Hon Ng as Chief Legal Officer, reinforcing its focus on compliance and regulatory engagement. With over 20 years of experience, Ng now leads efforts to expand in new markets and strengthen regulatory dialogues worldwide for Bitget. This appointment aligns with the company's goal of advancing crypto adoption through strong compliance.

In August, Bitget’s platform showed impressive growth, offering 800 tokens and 900 spot trading pairs, with daily trading volumes of $400 million in spot markets and $7 billion in futures. The platform’s protection fund remains strong at $400 million, ensuring user security.

“Bitget's constant innovation and advancements in security has made it one of the fastest growing exchanges. Adding over a million users consistently month–over–month has been a huge achievement for us and also shows the increasing participation in crypto from a wider audience,” says Gracy Chen, CEO at Bitget.

The introduction of new products, such as the Bitget Booster Platform, was also launched to connect crypto influencers with projects, offering content creators generous commission rewards. Additionally, the launch of P2P Shield strengthened security for peer–to–peer transactions, protecting users from fraud.

Bitget also achieved ISO 27001:2022 certification,showcasing its commitment to maintaining the highest standards of information security. As the platform expands, these developments keep Bitget strong as a leader in the crypto industry while ensuring user security and asset protection.

The platform currently boasts 185,000+ pro traders and over 840,000 copy trading followers, leading to more than 90 million successful trades. Profits from these trades have resulted in over $500 million in gains, with $23 million shared by elite traders.

On Bitget Wallet side, the decentralized wallet from Bitget's ecosystem introduced an MPC wallet with Telegram log–in, simplifying Web3 access by allowing users to create keyless wallets through their Telegram accounts. This innovation enhances security and usability, complemented by a new Telegram trading bot that offers real–time market updates and facilitates meme coin trading. Additionally, Bitget Wallet has integrated token lists from Four.Meme and Sun Pump for TRON and BNB Chain memecoins, upgraded transaction features, and pledged 2 million $TRX to subsidize gas fees, making trading faster, cheaper, and more user–friendly.

For more in–depth insights, visit Bitget's August Transparency Report.

About Bitget

Established in 2018, Bitget is the world's leading cryptocurrency exchange and Web3 company. Serving over 25 million users in 100+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions. Formerly known as BitKeep, Bitget Wallet is a world–class multi–chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, swap, NFT Marketplace, DApp browser, and more. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and Turkish National athletes Buse Tosun Çavuşoğlu (Wrestling world champion), Samet Gümüş (Boxing gold medalist) and İlkin Aydın (Volleyball national team).

For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet
For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices may fluctuate and experience price volatility. Only invest what you can afford to lose. The value of your investment may be impacted and it is possible that you may not achieve your financial goals or be able to recover your principal investment. You should always seek independent financial advice and consider your own financial experience and financial standing. Past performance is not a reliable measure of future performance. Bitget shall not be liable for any losses you may incur. Nothing here shall be construed as financial advice. For more information, see our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a615fb6–94c8–43bc–bb88–3b06a60d5bcc


GLOBENEWSWIRE (Distribution ID 1000991293)

“لايفيرا أوميكس” تعيّن خبير الجينوم الكريّع رئيساً للقسم الطبي والجينومي

  • لايفيرا أوميكس تستهدف تعزيز مكانة المملكة عالمياً في مجال الجينوم البشري متعدد الجينات.
  • لايفيرا، المملوكة بالكامل لصندوق الاستثمارات العامة، توسع نطاق عملياتها في لايفيرا أوميكس، وتستثمر في بناء فريق عالمي من الخبراء السعوديين والعالميين.

الرياض، المملكة العربية السعودية, Sept. 10, 2024 (GLOBE NEWSWIRE) —  أعلنت شركة لايفيرا أوميكس، المشروع المشترك الذي أُطلق في يناير 2024، تعيين الخبير العالمي والباحث السعودي في مجال علم الوراثة الجزيئي، البروفيسور فوزان سامي الكريّع، رئيساً للقسم الطبي والجينومي و اللذي سينضم لمجلس إدارة لايفيرا أوميكس ، ليساهم بخبرته الممتدة لأكثر من 17 عاماً في تحقيق أهداف الشركة الرامية لتطوير حلول مبتكرة في مجال الطب الجينومي.

برز الكريّع، الرئيس السابق لمركز الجينوميات الانتقالية بمستشفى الملك فيصل التخصصي ومركز الأبحاث في الرياض، والأستاذ الحالي لعلم الوراثة البشرية في جامعة الفيصل، كرائد في مجال الطب الجينومي، حيث ساهم بأكثر من 590 بحثاً علمياً نُشرت في مجلات عالمية مرموقة، وكمُتحدث رئيسي في المؤتمرات العلمية الدولية حول الطب الجيني والرعاية الصحية الدقيقة.

نال الكريّع عدة جوائز مرموقة من بينها جائزة وليام كنج بويز لطب الوراثة من معهد هارفارد للطب الشخصي في بوسطن، وجائزة الملك سلمان لأبحاث الإعاقة (فرع العلوم الصحية والطبية)، وجائزة ”كرت ستيرن” من الجمعية الأمريكية للوراثة البشرية، كأول فائز يحصل عليها من خارج الولايات المتحدة الأمريكية. و كما فاز بجائزة الكويت (فرع العلوم الطبية الأساسية), و جائزة الشيخ حمدان بن راشد آل مكتوم للعلوم الطبية.

حصل البروفيسور الكريّع –على شهادة البورد من جامعة هارفارد بالاضاقة إلى العديد من شهادات البورد المهنية، وحقق إنجازاتٍ بارزةً في مجال الوراثة البشرية، شملت اكتشاف الوظائف الفسيولوجية والتركيبية لمئات الجينات، ما ساعد في تشخيص العديد من الاعتلالات الوراثية، فضلاً عن أهمية اكتشافاته في تكريس مفهوم العلاقة الوثيقة بين الجينات وصحة الإنسان.

وفي هذا الصدد، علّق الدكتور إبراهيم الجفالي، رئيس مجلس إدارة شركة لايفيرا، قائلاً: “نحن سعداء بانضمام البروفيسور الكريّع إلى فريق العمل في لايفيرا أوميكس، وستكون الخبرات العلمية والعملية المتراكمة لديه أداة أساسية لمساعدة الشركة في تحقيق رسالتها الساعية لتعزيز مقدرات المملكة في قطاع الأدوية الحيوية وتمكين الاستراتيجية الوطنية للتقنية الحيوية“.

نبذة عن لايفيرا

لايفيرا، المملوكة بالكامل لصندوق الاستثمارات العامة، هي شركة متخصصة في إجراء التعاقدات المتعلقة بتطوير وتصنيع المنتجات الدوائية الحيوية (CDMO)، تم إطلاقها في عام 2023 ومقرها الرياض. تتمثل رسالة الشركة في تعزيز مقدرات المملكة في قطاع الأدوية الحيوية وتمكين الإستراتيجية الوطنية للتقنية الحيوية، في حين يكمن هدفها في تسويق وتطوير وصناعة العلاجات المتقدمة وغيرها من الأدوية واللقاحات الأساسية. في يناير 2023 أتمت لايفيرا الاستثمار في حصة الأغلبية بمصنع سعودي بيو المتخصص في تصنيع الأدوية البيولوجية في الرياض. وتعمل الشركة حالياً على تطوير هذا المصنع ليكون جاهزاً للتشغيل في عام 2026 وفق المعايير العالمية لتصنيع الأدوية بنظام التعاقد، ومن بينها الإنسولين وغيرها من الأدوية البيولوجية للشركات الدوائية العالمية الرائدة التي تخدم السوق السعودي والإقليمي. وتعمل لايفيرا على تطوير مقدرات تصنيع بيولوجية إضافية، عبر شركتها الفرعية لايفيرا أوميكس، وتمكن عملاءها من تطوير وتسويق العلاجات المتقدمة.

نبذة عن لايفيرا أوميكس

تأسست لايفيرا أوميكس، التابعة لشركة لايفيرا، في يناير 2024 لتطوير السعة المختبرية متعددة الجينوميات –الجافة والرطبة– على نطاق واسع وفق أعلى المعايير العالمية، وللمساعدة في تمكين أهداف الجينوم في الإستراتيجية الوطنية للتقنية الحيوية في المملكة. وتتعاون لايفيرا أوميكس مع العملاء لتلبية احتياجاتهم السريرية وصحة السكان والأبحاث والتطوير، وتهدف إلى تعزيز سرعة ودقة التشخيصات السريرية عبر أنظمة الرعاية الصحية في المملكة، وتمكين الطب الدقيق للأمراض النادرة والمتكررة، من خلال الحلول المبتكرة القائمة على البيانات، والاستفادة من الخبرة الرائدة في مجال التشخيص والشراكات.

contact@liferaomics.com.sa

https://www.globenewswire.com/NewsRoom/AttachmentNg/3b2d5898–1176–4073–a7c7–4e7891ab6d3e/ar الصورة المصاحبة لهذا الإعلان متاحة على


GLOBENEWSWIRE (Distribution ID 9228307)

Lifera Omics Appoints Prof. Fowzan Alkuraya, a Renowned Genomics Expert as Chief Medical and Genomic Officer

  • Lifera, a biopharma company wholly owned by the Public Investment Fund (PIF), launched in 2023, is scaling up its subsidiary Lifera Omics and developing a team of leading Saudi and global talent to fulfil its mission
     
  • Lifera Omics aims to elevate Saudi Arabia’s role in multiomics globally

RIYADH, Saudi Arabia, Sept. 10, 2024 (GLOBE NEWSWIRE) — Lifera Omics, a subsidiary of Lifera that was launched in January 2024, announced the appointment of renowned Saudi human geneticist, Prof. Fowzan Sami Alkuraya, as its Chief Medical and Genomics Officer, who will be also added to the Board of Lifera Omics. Prof. Alkuraya’s deep experience in human genomics built over 17 years will contribute significantly in enabling Lifera Omics’ objectives.

Prof. Alkuraya, a former Chairman of Translational Genomics at King Faisal Specialist Hospital and Research Centre in Riyadh and current Professor of Human Genetics at Alfaisal University, has significantly contributed to the field of genomics, through over 590 scientific publications in prestigious international journals and as a frequent speaker at international scientific conferences on genomic medicine and precision health.

Prof. Alkuraya garnered numerous prestigious awards, including the William King Wilson Prize in Genetics from Harvard Medical School, the King Salman Award for Disability Research, and the Curt Stern Award from the American Society of Human Genetics – the first non–US based recipient of this honor. He also won Kwiat Prize for Basic Medical Science Subject Area and Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.

Prof. Alkuraya was granted his post graduate board certification from Harvard University, in addition to several other board certifications. His contributions to human genetics have been instrumental in elucidating the physiological and structural roles of hundreds of genes, resulting in the diagnosis of many genetic disorders. His discoveries have significantly advanced the understanding of the intricate relationship between human genes and health.

“We are delighted to welcome such a trusted and respected leader to the Lifera Omics Executive Leadership team,” said Dr. Ibrahim Juffali, Chairman of Lifera. “Dr. Fowzan’s deep clinical and scientific expertise will be instrumental in helping Lifera achieve its mission to improve Saudi Arabia’s biopharma resilience and to enable the National Biotech Strategy.”

About Lifera

Lifera is a biopharma contract and development manufacturing organization (CDMO) wholly owned by the Public Investment Fund (PIF), launched in 2023 based in Riyadh, Saudi Arabia. Lifera’s mission is to improve Saudi Arabia’s biopharma resilience and enable the National Biotech Strategy. Lifera’s goal is to commercialize, develop and manufacture advanced therapeutics and other life–saving and essential medicines and vaccines. In January 2023, Lifera completed a majority stake investment in SaudiBio, a brownfield biologics drug product manufacturing plant in Riyadh. Lifera is currently upgrading this plant to be commissioned in 2026 to global standards to contract manufacture insulins, biosimilars and other biologics for leading global pharmaceutical companies serving the KSA and regional markets. Lifera is in the process of developing additional biomanufacturing capacity and through its subsidiary Lifera Omics, further enables Lifera’s customers to develop and commercialize advanced therapeutics.

About Lifera Omics

Lifera Omics, a subsidiary of Lifera, was established in January 2024 to develop at–scale multiomic dry and wet lab capacity to the highest global standards and to help enable the genomics goals of Saudi Arabia’s National Biotech Strategy. Lifera Omics partners with customers to serve their clinical, population health and R&D needs. Lifera Omics aims to enhance the speed and accuracy of clinical diagnoses across health systems in Saudi Arabia, and to enable precision medicine for rare and common diseases through innovative, data–driven solutions, leveraging industry–leading diagnostic expertise and partnerships.

contact@liferaomics.com.sa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3b2d5898–1176–4073–a7c7–4e7891ab6d3e


GLOBENEWSWIRE (Distribution ID 9228307)

Zoom Appoints Mike Fenger to Board of Directors

SAN JOSE, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) announced that it has appointed Mike Fenger, vice president Worldwide Sales, Apple, as an independent director on Zoom’s Board of Directors effective immediately.

“Zoom plays an important role connecting people around the world, and I’m excited to join the Board and contribute to its future success,” said Mike Fenger, vice president Worldwide Sales, Apple. “Eric Yuan has built a great team and the company’s dedication to driving innovative technology is inspiring. I’m really looking forward to working with them.”

“On behalf of Zoom’s Board of Directors, I am thrilled to welcome Mike to the team,” said Zoom founder and CEO Eric S. Yuan. “Mike’s experience at Apple, and companies including GE, and his proven track record of global leadership bring valuable insights that align perfectly with our vision. We’re excited to see the fresh perspective and innovative ideas he’ll contribute as we continue driving our growth and success.”

About Mike Fenger

Mike oversees global product sales for Apple, and his team plays an important part in helping customers discover products they love. Since joining Apple in 2008, he has also had a key role in strengthening telecommunications and consumer electronic reseller partnerships, and deepening connections with customers in enterprise, education, and government. He began his Apple career as vice president of Global iPhone Sales, where he led the expansion of iPhone distribution to customers around the globe.

Mike has over 20 years of experience building and leading sales teams for global companies. Before joining Apple, he held senior positions at General Electric and Motorola, where he helped develop and execute strategy for sales, operations, marketing, and supply chain management in the Americas, Europe, and Greater China. Mike is a graduate of Miami University, where he earned a bachelor’s degree in Economics.

About Zoom
Zoom’s mission is to provide one platform that delivers limitless human connection. Reimagine teamwork with Zoom Workplace — Zoom’s open collaboration platform with AI Companion empowers teams to be more productive. Together with Zoom Workplace, Zoom’s Business Services for sales, marketing, and customer care teams, including Zoom Contact Center, strengthen customer relationships throughout the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more information at zoom.com.

Zoom PR
Colleen Rodriguez
Head of Global PR
press@zoom.us


GLOBENEWSWIRE (Distribution ID 9220130)

DigiAsia Corp. Appoints Andreas Gregori to its AI Strategic Advisory Board

~ The Addition Strengthens the Delivery of Meaningful AI Fintech Solutions for its Enterprise Clients ~

NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — DigiAsia Corp. (NASDAQ: FAAS) (“DigiAsia” or the “Company”), a leading Fintech as a Service (“FaaS”) ecosystem provider, today announced that Andreas Gregori, a current member of DigiAsia’s board of directors and highly experienced business executive and entrepreneur, has been appointed as an advisor to its recently established AI strategic advisory board. Mr. Gregori is a seasoned commercial leader with a digital and customer–first mindset. His deep knowledge of leveraging technology and AI in meaningful ways will propel the Company as it rapidly integrates AI solutions to enhance its Fintech offerings for enterprise clients and partners in Indonesia and beyond.

Mr. Gregori has over 15 years of global C–suite experience within leading technology and telecommunications companies with vast experience driving growth through bold commercial and technology programs for multi–billion–dollar organizations and start–ups in both mature and emerging markets. Since 2019, Mr. Gregori has served as President of Axiom D Inc., where he devises new digital revenue streams and business models around innovative value propositions, customer value management and data monetization. Previously, Mr. Gregori served as Chief Marketing Officer and Chief Digital Officer of Indosat Ooredoo, Indonesia’s second largest telecommunications provider, where he led the successful company transformation to establish itself as a leading digital telco in Indonesia. Mr. Gregori has a Ph.D. in Computer Science and Artificial Intelligence from Technische Universitat Berlin, Germany, and an M.S. in Computer Science from Technische Universitat Darmstadt, Germany.

Prashant Gokarn, CEO of DigiAsia, commented, “We are honored that industry veteran Andreas has further dedicated his time and experience to our AI advisory team. Andreas’ leadership, technological acumen and customer–first mindset have proven to drive operational growth through bold innovations. His expertise will be instrumental as we accelerate the development and deployment of innovative AI fintech solutions that deliver significant value to our clients and contribute to sustained economic growth.”

Andreas Gregori added, “I am excited to deepen my involvement with DigiAsia as a member of its AI strategic advisory board. DigiAsia already powers significant parts of the digital value chain for Indonesia’s leading enterprises, and I am eager to contribute to the development of its next generation fintech solutions. By leveraging AI and our access to Nvidia’s cutting–edge GPUs, we can create powerful tools to drive enterprise growth across the region.”

About DigiAsia

DigiAsia is a leading Fintech as a Service (FaaS) provider in Indonesia and nearby emerging markets and digitizing finance across the commerce ecosystem operating as a B2B2X model. DigiAsia’s fintech architecture offers municipalities and small and medium enterprise business (SME) comprehensive embedded finance APIs to streamline processes across the commerce value chain. DigiAsia’s embedded fintech solutions equally address democratizing digital finance access that supports financial inclusion of underbanked merchants and consumers in emerging markets resulting in growth for enterprise business. The suite of B2B2X solutions provided by DigiAsia include, but are not limited to, cashless payments, digital wallets, digital banking, remittances and banking licenses. DigiAsia has recently established a strategic initiative to develop its embedded FaaS enterprise solution with AI capabilities in Southeast Asia, India, and the Middle East, with plans for global expansion. For more information, please visit DigiAsia’s Corporate website here or Investor Relations website here.

Forward–Looking Statements:

This press release may contain forward–looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “expect”, “anticipate”, “project”, “targets”, “optimistic”, “confident that”, “continue to”, “predict”, “intend”, “aim”, “will” or similar expressions are intended to identify forward–looking statements. All statements other than statements of historical fact are statements that may be deemed forward–looking statements. These forward–looking statements including, but not limited to, statements concerning DigiAsia and the Company’s operations, financial performance and condition are based on current expectations, beliefs and assumptions which are subject to change at any time. DigiAsia cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors such as government and stock exchange regulations, competition, political, economic and social conditions around the world including those discussed in DigiAsia’s Form 20–F under the headings “Risk Factors”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business Overview” and other reports filed with the Securities and Exchange Commission from time to time. All forward–looking statements are applicable only as of the date it is made and DigiAsia specifically disclaims any obligation to maintain or update the forward–looking information, whether of the nature contained in this release or otherwise, in the future.

DigiAsia Company Contact:
Subir Lohani
Chief Financial Officer and Chief Strategy Officer
646–480–0142

Investor Contact:
MZ North America
Email: FAAS@mzgroup.us


GLOBENEWSWIRE (Distribution ID 9217207)

Infectious Disease Expert Kelly Warfield Named Sabin’s New R&D President

caption: Sabin Vaccine Institute Research & Development President Kelly Warfield

WASHINGTON, Aug. 20, 2024 (GLOBE NEWSWIRE) — Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin’s current candidate vaccines toward licensure and expand its pipeline.

A member of Sabin’s executive team, Warfield will manage the R&D program and team, collaborating with peers, cross–functional heads, and the Board of Trustees to shape Sabin’s strategic vision. She will report to CEO Amy Finan, who has led the R&D team since 2017 and revitalized it by launching new programs, securing new funding, and enhancing its capabilities.

“With our success comes the need for a new leader with the scientific, regulatory, and business experience to propel our R&D work forward and enable me to focus on growing Sabin,” says Finan. “This is the right time to make that move, and we have the right person for the role in Kelly Warfield.”

A seasoned executive and scientist, Warfield brings a wealth of experience in guiding life science teams to build new competencies and advance vaccine programs across various sectors, including government, start–ups, and mid–sized biotech/pharma companies. In her most recent role as senior vice president for science & development at Emergent BioSolutions, she managed a multinational team of over 300 scientists with an annual budget exceeding $100 million, and coordinated partnerships with BARDA, NIAID, the U.S. Department of Defense, and CEPI.

“Kelly brings the strategic and scientific leadership needed to advance Sabin’s two vaccine candidates to licensure and expand our vaccine portfolio. Just as importantly, she has the passion and expertise to tackle the technical and operational challenges of developing vaccines for diseases that disproportionately impact people in under–resourced settings,” says Finan.

Warfield says she’s honored to be Sabin’s first R&D president and deeply inspired by the organization’s ethos. “Throughout my career, I have focused on addressing unmet medical needs via public–private partnerships,” she says. “My greatest fulfillment comes from developing vaccines to combat those emerging disease threats. So, this role at Sabin aligns perfectly with my long–held interest in using science to help those most in need.”

A critical priority for Warfield will be to work with partners to bring Sabin’s candidate vaccines against Marburg and Sudan ebolavirus diseases to licensure. “These vaccines, if licensed, could be game–changers, especially for communities in outbreak–prone regions of Africa,” says Warfield.

Beyond her expertise in vaccine development, Kelly has a deep understanding of novel regulatory pathways, including the Animal Rule and Accelerated Approval processes. She has successfully navigated U.S. FDA and European Medicines Agency regulations for product approvals.

Prior to joining Emergent in 2014, Warfield co–founded Integrated Biotherapeutics, Inc. and led its vaccine development, specializing in the development of antivirals and vaccines for Ebola and Marburg viruses. She has also led preclinical development for a wide array of antivirals, including influenza and dengue.

Warfield began her research career as a student intern at the National Cancer Institute. As a National Research Council postdoctoral fellow at the United States Army Medical Research Institute of Infectious Diseases, she developed vaccines and therapeutics for highly lethal filoviruses and received training to work in advanced biosafety (BSL–3 and BSL–4) containment laboratories.

Warfield has authored over 100 publications and book chapters and holds more than 15 patents.

In addition to her professional achievements, Warfield has served on the boards of non–profits and start–ups, and currently advises an organization that provides STEM opportunities to underserved communities.

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non–profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on X, @SabinVaccine.

Media Contact:
Monika Guttman
Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 662–1841
press@sabin.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/440f3fa4–a78f–4d8a–85c4–e84724a6c69b


GLOBENEWSWIRE (Distribution ID 9217160)

Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024.

Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE: UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ: PTC) from 2021 until 2022 after having served as executive vice president and chief operating officer from 2020 to 2021. Mr. Richardson’s three decades of senior leadership roles span some of the largest and most successful global technology companies including DXC (formerly Computer Sciences Corporation prior to its merger with HP Enterprise), Oracle, SAP, Hewlett–Packard Novell, and IBM. With the appointment of Troy Richardson, Cellebrite’s Board of Directors now consists of 10 directors. Mr. Richardson is based in metropolitan Atlanta.

“We are delighted to welcome Troy to our board of directors,” said Thomas Hogan, Executive Chairman of the Board of Cellebrite. “Troy is an outstanding leader who brings a wealth of expertise and insight to our Company. His deep knowledge of the software industry, combined with his broad leadership experience spanning sales, marketing, corporate development and customer success, will be invaluable as we continue to execute our strategy and deliver outstanding value to our customers. We look forward to benefiting from Troy’s counsel as we further scale our business, fortify and expand our market leadership, advance innovation and drive shareholder value.”

“I am honored and excited to join Cellebrite's board of directors,” said Richardson. “Cellebrite has established its leadership position in the digital investigative and intelligence gathering industry, with a strong culture of innovation, customer focus, and social responsibility. I look forward to collaborating with Tom and the rest of the Board, as well as with Cellebrite’s talented management team and employees, to help Cellebrite achieve its full potential and continue making a positive, enduring impact on the world.”

Mr. Richardson holds a bachelor's degree in business administration from Eastern Illinois University and a master's degree in business administration from Northwestern University’s J.L. Kellogg School of Management. He was appointed to Unisys’ Corporation’s Board of Directors in 2021 and currently serves on the Board’s Audit & Finance and Rick & Security Committees. Mr. Richardson also served on Carestream Dental Board of Directors from 2021 to 2024.

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigative platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on X at @Cellebrite.

Contacts:

Media
Victor Ryan Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

Investors
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/947dd533–8273–47a0–9fdb–eac0d18d28c5


GLOBENEWSWIRE (Distribution ID 9204183)

Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the appointment of Sigalit Shavit as Chief Information Officer (CIO) who begins her role today, August 1, 2024.

Shavit joins the Company’s Leadership Team, bringing with her more than 30 years of experience to Cellebrite’s information technology and security team. In this newly established position that reports to CEO Yossi Carmil, Shavit will play a pivotal role in scaling the Company’s ability to innovate and support customers as they strive to continue accelerating justice around the globe.

Shavit joins Cellebrite at a time when the Company’s technical innovation and infrastructure is paramount to supporting customers to stay ahead of the growing sophistication of criminals and the ever–increasing growth of digital evidence. She will focus on ensuring that Cellebrite’s information technology and security organizations continue supporting the day–to–day needs of the business, responding decisively to ever–evolving cyber threats, leveraging AI and accelerating innovation.

“Sigalit’s expertise in information technology and security and enabling innovation for enterprise SaaS companies, elevates Cellebrite’s ability to advance its mission of accelerating justice,” said Cellebrite CEO Yossi Carmil. “We are fortunate to gain both her knowledge and leadership, which allows us to better serve our customers and employees.”

Named one of the Top 25 Women Leaders in Cybersecurity in multiple publications, Shavit has held CIO and COO roles with FedEx Express, ECI Telecom, CyberArk and most recently KTrust. During her tenure with CyberArk, she played a critical role through its transformation to an enterprise–grade cloud/SaaS company.

“It is a great honor to be here and lead a team that empowers and propels Cellebrite and its customers forward,” Shavit said. “I am passionate about my team’s significant mission of harnessing a clear, modern digital strategy and solutions to make an impact on efficiency and accelerating innovation.”

About Cellebrite 

Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigative platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on X at @Cellebrite.

Media 
Victor Ryan Cooper 
Sr. Director of Corporate Communications + Content Operations 
Victor.cooper@cellebrite.com 
+1 404.804.5910 

Investor Relations 
Andrew Kramer 
Vice President, Investor Relations 
investors@cellebrite.com 
+1 973.206.7760

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e4793d6b–ce54–4dd5–af87–642468ab62e7


GLOBENEWSWIRE (Distribution ID 9195919)

DigiAsia Corp. Forms AI Focused Strategic Advisory Board and Appoints Gulzar Azad as a Strategic Advisor

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) — DigiAsia Corp. (NASDAQ: FAAS) (“DigiAsia” or the “Company”), a leading Fintech as a Service (“FaaS”) ecosystem provider, today announced that Gulzar Azad, an accomplished technology leader and entrepreneur, is DigiAsia's first appointee as a strategic advisor to its recently established AI strategic advisory board. DigiAsia’s formation of an advisory board serves a critical purpose in navigating the trajectory of the Company as it rapidly introduces AI technology and capabilities to provide efficiency to enterprise clients in Indonesia at scale. Mr. Azad’s motivation to democratize technology through innovation will significantly benefit DigiAsia's initiatives to build its AI infrastructure and the AI as a Service business.

Mr. Azad currently serves in an advisory role of Health AI and population–scale projects at Google UK and is a Google veteran, having led several early initiatives for product partnerships in India and APAC since 2007. Additionally, Mr. Azad’s experience includes contributions to launch mobile search in India of Android and pioneered strategic projects for high–speed connectivity and software defined networks for Telecom operators.

Prashant Gokarn, CEO of DigiAsia, commented, “We are thrilled to welcome Gulzar to our newly formed AI driven advisory team. His vision and experience in the technology sector perfectly aligns with our goals to expand DigiAsia’s AI capabilities across our SME ecosystem while concurrently making AI more accessible to drive further economic growth in Indonesia. His insights will be invaluable as we continue to innovate and grow DigiAsia’s presence in AI.”

Gulzar Azad added, “I am excited to support DigiAsia in this new capacity as my history and close experience with advancing technology equity and creating distributed architectures to benefit the broader ecosystem is complementary to management’s mission to drive commerce growth across Indonesia and its trading partners in Southeast Asia. Together, we will work towards democratizing AI infrastructure, ensuring it benefits a broader range of stakeholders and fosters innovation across various sectors.”

About DigiAsia

DigiAsia is a leading Fintech as a Service (FaaS) provider operating a B2B2X model offering its complete Fintech solution in emerging markets. DigiAsia’s fintech architecture offers small and medium business enterprises (SMEs) comprehensive embedded finance APIs to streamline processes across the commerce value chain of distributors and customers. DigiAsia’s embedded fintech solutions equally address democratizing digital finance access that supports financial inclusion of underbanked merchants and consumers in emerging markets resulting in growth for enterprise business. The suite of B2B2X solutions provided by DigiAsia include, but are not limited to, cashless payments, digital wallets, digital banking, remittances and banking licenses. DigiAsia has recently established a strategic initiative to develop its embedded FaaS enterprise solution with AI capabilities in Southeast Asia, India, and the Middle East, with plans for global expansion. For more information visit: Corporate website here or Investor website here.

Forward–Looking Statements:

This press release may contain forward–looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “expect”, “anticipate”, “project”, “targets”, “optimistic”, “confident that”, “continue to”, “predict”, “intend”, “aim”, “will” or similar expressions are intended to identify forward–looking statements. All statements other than statements of historical fact are statements that may be deemed forward–looking statements. These forward–looking statements including, but not limited to, statements concerning DigiAsia and the Company’s operations, financial performance and condition are based on current expectations, beliefs and assumptions which are subject to change at any time. DigiAsia cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors such as government and stock exchange regulations, competition, political, economic and social conditions around the world including those discussed in DigiAsia’s Form 20–F under the headings “Risk Factors”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business Overview” and other reports filed with the Securities and Exchange Commission from time to time. All forward–looking statements are applicable only as of the date it is made and DigiAsia specifically disclaims any obligation to maintain or update the forward–looking information, whether of the nature contained in this release or otherwise, in the future.

DigiAsia Company Contact:

Subir Lohani

Chief Financial Officer and Chief Strategy Officer

646–480–0142

Investor Contact:

MZ North America

Email: FAAS@mzgroup.us


GLOBENEWSWIRE (Distribution ID 9195282)

GMAC Board Election Affirms Continuity, Drive toward Business for Good

RESTON, Va., July 17, 2024 (GLOBE NEWSWIRE) — The Graduate Management Admission Council (GMAC), a non–profit association representing over 200 graduate business schools around the globe, today announced the election to her first full term of Itziar de Ros, associate dean of advancement and engagement at IESE Business School, and the re–election of François Ortalo–Magné, dean of London Business School, to another term of four years to its board of directors. In addition, Jay Nibbe, former global vice chair of markets at EY, was re–appointed for a second term. All three started their new term on July 1, 2024.

With the GMAC board’s continuity confirmed by its member schools, it also reiterates its commitment to the organization’s mission to serve prospective candidates with talent and aspirations in business careers and school professionals who are passionate about holistic admission practices to build an inclusive classroom while delivering high quality education and services to their students.

“For seven decades, we have been known for providing business schools with assessment tools that give insight into a prospective student’s readiness for the academic rigor of their programs. Equally important is how we also educate school professionals in the latest marketing and recruiting approaches to deepen the global candidate pipeline, ensure that our conference and event curriculum remains robust and addresses immediate industry needs, and continue to inform schools on what we are learning about the pipeline through our research that takes a deeper dive into special segments and global regions,” said Joy Jones, CEO of GMAC. “Our newly confirmed board, along with our staff across continents, recognizes our long–term investment in both the business schools and the candidates aspiring to enter them. We remain driven toward realizing the vision of a world where every talented person can benefit from the best business education for them, knowing that business school graduates are motivated to take on some of our greatest challenges.”

GMAC programs, products, and services are widely available, and the organization takes additional measures to ensure everyone with aspirations has opportunity. GMAC’s commitment to cultivating an inclusive talent pipeline spans decades. 30 years ago, GMAC co–founded The PhD Project, an organization with an aim to positively impact the diversity of the workforce by changing faculty representation, and for 20 years has supported the Forté Foundation, whose mission is to propel women to successful careers through access to business education and opportunities. Donations to these and other pipeline organizations have surpassed $6 million. Well into its third year, the GMAT Talent and Opportunity Scholarship has benefited dozens of business school aspirants from underrepresented communities in Europe to promote business school inclusivity. GMAC Tours hosts virtual and in–person spotlight events specifically for MBA applicants in the veteran community in partnership with Service to School, a non–profit that provides free graduate school application counseling to military veterans and servicemembers, and for Black, Hispanic, and Native American candidates in partnership with Management Leadership for Tomorrow, a non–profit focusing on building diverse leaders and equitable workspaces. In its desire to positively impact the communities in which it operates, GMAC introduced a service activity as part of the program at last month’s GMAC Annual Conference for all attendees to support students in the local New Orleans area.

“In 2023, GMAC issued a sustainable development statement and one of our aims is to contribute to the growth and equality in the communities that we serve while caring for the environment where we operate. I am impressed by how GMAC has strived to grow along with—and give back to—our business school community, and our society at large, through efforts toward building an inclusive and quality business education ecosystem,” said Themin Suwardy, associate provost of postgraduate professional education at Singapore Management University and chair of the GMAC Board.

GMAC also recognizes and thanks its outgoing board member Yuan Ding, Cathay Capital Chair Professor in Accounting at CEIBS (China Europe International Business School), for his continuous support of GMAC’s mission over the past four years.

About GMAC

The Graduate Management Admission Council (GMAC) is a mission–driven association of leading graduate business schools worldwide. GMAC provides world–class research, industry conferences, recruiting tools, and assessments for the graduate management education industry as well as resources, events, and services that help guide candidates through their higher education journey. Owned and administered by GMAC, the Graduate Management Admission Test™ (GMAT™) exam is the most widely used graduate business school assessment.

More than 12 million prospective students a year trust GMAC’s platforms, including mba.com, GMAC Tours, and BusinessBecause, to learn about MBA and business master’s programs, connect with schools around the world, prepare and register for exams, and get advice on how to successfully achieve their business education and career goals. GMAC is a global organization with offices in China, India, the United Kingdom, and the United States.

To learn more about our work, please visit www.gmac.com

Media Contact:

Teresa Hsu
Sr. Manager, Media Relations
Mobile: 202–390–4180
thsu@gmac.com


GLOBENEWSWIRE (Distribution ID 9178385)